[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0671933T3 - Hidtil ukendte anvendelser af IL-10 - Google Patents

Hidtil ukendte anvendelser af IL-10

Info

Publication number
DK0671933T3
DK0671933T3 DK93920050T DK93920050T DK0671933T3 DK 0671933 T3 DK0671933 T3 DK 0671933T3 DK 93920050 T DK93920050 T DK 93920050T DK 93920050 T DK93920050 T DK 93920050T DK 0671933 T3 DK0671933 T3 DK 0671933T3
Authority
DK
Denmark
Prior art keywords
new uses
alone
optionally
manufacture
combination
Prior art date
Application number
DK93920050T
Other languages
Danish (da)
English (en)
Inventor
Donna Rennick
Waal Malefyt Rene De
Robert Coffman
Vries Jan E De
Fiona Powrie
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/932,900 external-priority patent/US5368854A/en
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0671933T3 publication Critical patent/DK0671933T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
DK93920050T 1992-08-20 1993-08-18 Hidtil ukendte anvendelser af IL-10 DK0671933T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US07/932,900 US5368854A (en) 1992-08-20 1992-08-20 Use of IL-10 to treat inflammatory bowel disease
US93395092A 1992-08-21 1992-08-21
US93341992A 1992-08-21 1992-08-21
US93346292A 1992-08-21 1992-08-21
PCT/US1993/007646 WO1994004180A2 (en) 1992-08-20 1993-08-18 Novel uses of il-4 and/or il-10, and antibodies against the same

Publications (1)

Publication Number Publication Date
DK0671933T3 true DK0671933T3 (da) 1998-09-23

Family

ID=27506019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93920050T DK0671933T3 (da) 1992-08-20 1993-08-18 Hidtil ukendte anvendelser af IL-10

Country Status (23)

Country Link
EP (2) EP0801951A3 (ko)
JP (1) JP3494647B2 (ko)
KR (1) KR0170037B1 (ko)
CN (1) CN1090204A (ko)
AT (1) ATE162947T1 (ko)
AU (1) AU680628B2 (ko)
CA (1) CA2142861C (ko)
CZ (1) CZ283488B6 (ko)
DE (1) DE69316921T2 (ko)
DK (1) DK0671933T3 (ko)
ES (1) ES2111769T3 (ko)
FI (1) FI950697A (ko)
GR (1) GR3026635T3 (ko)
HK (1) HK1004326A1 (ko)
HU (1) HU220103B (ko)
IL (1) IL106725A (ko)
MX (1) MX9305054A (ko)
MY (1) MY111402A (ko)
PL (1) PL307566A1 (ko)
RU (1) RU2120802C1 (ko)
SK (1) SK21195A3 (ko)
TW (1) TW243415B (ko)
WO (1) WO1994004180A2 (ko)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6000894A (en) * 1993-02-01 1994-08-29 Michel Goldman Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
AU686816B2 (en) * 1994-07-05 1998-02-12 Steeno Research Group A/S Immunomodulators
DE69534265T2 (de) 1994-12-12 2006-05-04 Beth Israel Deaconess Medical Center, Inc., Boston Chimäre zytokine und ihre verwendung
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
EP0756871A1 (en) * 1995-08-01 1997-02-05 Institut Pasteur Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
IL126623A0 (en) * 1996-04-17 1999-08-17 Prendergast Patrick T Pharmaceutical compositions and kits for dhea combined therapy
AU5532098A (en) * 1996-12-20 1998-07-17 Magainin Pharmaceuticals, Inc. A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6001651A (en) * 1998-03-20 1999-12-14 Isis Pharmaceuticals Inc. Antisense modulation of LFA-3
AU770726B2 (en) * 1998-10-20 2004-02-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of a cytokine-producing lactococcus strain to treat colitis
CA2362381C (en) 1999-02-10 2009-12-22 Welfide Corporation Amide compounds and medicinal use thereof
JP2003518627A (ja) * 1999-12-03 2003-06-10 バクスター・インターナショナル・インコーポレイテッド 自動イムノアッセイシステムを用いる使用のための発熱性試験
US6896885B2 (en) * 2000-03-31 2005-05-24 Biogen Idec Inc. Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
CA2408691A1 (en) 2000-05-12 2001-11-22 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for achieving immune suppression
US20040197304A1 (en) 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
US7261882B2 (en) * 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
AR046833A1 (es) * 2003-11-10 2005-12-28 Schering Corp Anticuerpos anti-interleuquina-10
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
CA2609617C (en) 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
ES2399987T3 (es) * 2005-10-03 2013-04-04 Actogenix N.V. Uso de una cepa de levadura recombinante que produce un compuesto antiinflamatorio en la fabricación de un medicamento para tratar colitis
WO2008054585A2 (en) * 2006-09-28 2008-05-08 Schering Corporation Use of pegylated il-10 to treat cancer
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9943568B2 (en) * 2013-04-18 2018-04-17 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating cancer
JP2016528879A (ja) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド タンパク質の同一性および安定性を評価する方法
PL3021873T3 (pl) 2013-07-18 2019-01-31 Xalud Therapeutics, Inc. Kompozycja do leczenia choroby zapalnej stawów
CA2920679A1 (en) 2013-08-30 2015-03-05 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2017035232A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
SK279556B6 (sk) * 1991-01-16 1998-12-02 Schering Corporation Liečivo na liečenie nádorov pacienta
GB9207732D0 (en) * 1992-04-06 1992-05-27 Isis Innovation Wound repair

Also Published As

Publication number Publication date
CA2142861A1 (en) 1994-03-03
WO1994004180A3 (en) 1994-06-09
PL307566A1 (en) 1995-05-29
KR950702841A (ko) 1995-08-23
CZ44195A3 (en) 1995-10-18
HU9500467D0 (en) 1995-04-28
AU680628B2 (en) 1997-08-07
RU2120802C1 (ru) 1998-10-27
SK21195A3 (en) 1996-10-02
KR0170037B1 (ko) 1999-02-01
EP0671933B1 (en) 1998-02-04
MX9305054A (es) 1994-02-28
ES2111769T3 (es) 1998-03-16
AU5010893A (en) 1994-03-15
FI950697A (fi) 1995-04-07
MY111402A (en) 2000-04-29
DE69316921T2 (de) 1998-06-04
TW243415B (ko) 1995-03-21
EP0801951A3 (en) 1998-05-20
CN1090204A (zh) 1994-08-03
HUT70976A (en) 1995-11-28
ATE162947T1 (de) 1998-02-15
IL106725A0 (en) 1993-12-08
DE69316921D1 (de) 1998-03-12
CZ283488B6 (cs) 1998-04-15
EP0671933A1 (en) 1995-09-20
GR3026635T3 (en) 1998-07-31
CA2142861C (en) 2000-08-15
IL106725A (en) 2000-12-06
JPH08500362A (ja) 1996-01-16
HU220103B (hu) 2001-10-28
HK1004326A1 (en) 1998-11-20
WO1994004180A2 (en) 1994-03-03
EP0801951A2 (en) 1997-10-22
RU95108330A (ru) 1996-11-27
JP3494647B2 (ja) 2004-02-09
FI950697A0 (fi) 1995-02-16

Similar Documents

Publication Publication Date Title
DK0671933T3 (da) Hidtil ukendte anvendelser af IL-10
ATA188592A (de) Alkyl-bisacylphosphinoxide, diese enthaltende zusammensetzungen und ihre verwendung
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
DK0791571T3 (da) Benzoylderivater
BR9205818A (pt) Composições azeotrópicas de 1,1,2,2-tetrafluororetano e semelhantes.
FI941570A0 (fi) Katalyyttikoostumus
DE69203695D1 (de) Sauerstoff aufnehmende Zusammensetzung.
DE69114184D1 (de) Harzzusammensetzung für Grundierung und Grundierungsmittel davon.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DE69017969D1 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
DE69004079D1 (de) Antioxidationszusammensetzungen.
FI923751A (fi) Hexahydrobenso/f/kinolinoner
MX9202320A (es) Composiciones cohesivas.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
IT233618Y1 (it) miscelatore di tipo perfezionato.
FI921343A0 (fi) Kombinerat steriliserat varmvatten- och braennsystem.
IT232448Y1 (it) Tavolo smontabile di tipo perfezionato.
FI931028A0 (fi) Sokkelokammio
DK1260222T3 (da) Farmaceutiske præparater indeholdende hidtil ukendte iso-butenyl-substituerede taxaner